Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study

Journals of Gerontology - Series B Psychological Sciences and Social Sciences

Volumn 55, Issue 2, 2000, Pages

  Riley, Kathryn P ^a,d   Snowdon, David A ^a   Saunders, Ann M ^b   Roses, Allen D ^b   Mortimer, James A ^c   Nanayakkara, Nuwan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; FEMALE; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0034012021     PISSN: 10795014     EISSN: None     Source Type: Journal    
DOI: 10.1093/geronb/55.2.S69     Document Type: Article

References (54)

1. Albert, M. S., Savage, C. R., Blazer, D., Jones, K., Berkman, L., Seeman, T., & Rowe, J. W. (1995). Predictors of cognitive change in older persons: MacArthur Studies of Successful Aging. Psychology and Aging, 10, 578-589.
2. Allison, P. D. (1995). Survival analysis using the SAS system: A practical guide. Cary, NC: SAS Institute.
3. Altstiel, L. D., Greenberg, D. A., Marin, D., Lantz, M., & Mohs, R. (1997). Apolipoprotein E genotype and cognition in the very old. Lancet, 349, 1451.
4. Baltes, P. B. (1993). The aging mind: Potential and limits. The Gerontologist, 33, 580-594.
5. Berr, C., Dufouil, C., Brousseau, T., Richard, F., Amouyel, P., Marceteau, E., & Alpérovitch, A. (1996). Early effect of ApoE-ε4 allele on cognitive results in a group of highly performing subjects: The EVA study. Neuroscience Letters, 218, 9-12.
6. Bondi, M. W., Salmon, D. P., Monsch, A. U., Galasko, D., Butters, N., Klauber, M R., Thal, L. J., & Saitoh, T. (1995). Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology, 45, 2203-2206.
7. Borkowski, J. G., Beuten, A. L., & Spreen, O. (1967). Word fluency and brain damage. Neuropsychologia, 5, 135-140.
8. Corder, E. H., Lannfelt, L., Viitanen, M., Corder, L. S., Manton, K. G., Winblad, B., & Basun, H. (1996). Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Archives of Neurology, 53, 418-422.
9. Evans, D. A., Beckett, L. A., Albert, M. S., Hebert, L. E., Scherr, P. A., Funkenstein, H. H., & Taylor, J. O. (1993). Level of education and change in cognitive function in a community population of older persons. Annals of Epidemiology, 3, 71-77.
10. Evans, D. A., Beckett, L. A., Field, T. S., Feng, L., Albert, M. S., Bennett, D. A., Tycko, B., & Mayeux, R. (1997). Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. Journal of the American Medical Association, 277, 822-824.
11. Fairer, L. A., Cupples, A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N., & van Duijn, C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: A meta-analysis. Journal of the American Medical Association, 278, 1349-1356.
12. Feskens, E. J. M., Havekes, L. M., Kalmijn, S., de Knijff, P., Launer, L. J., & Kromhout, D. (1994). Apolipoprotein E4 allele and cognitive decline in elderly men. British Medical Journal, 309, 1202-1206.
13. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
14. Haan, M. N., Shemanski, L., Jagust, W. J., Manolio, T. A., & Kuller, L. (1999). The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. Journal of the American Medical Association, 282, 40-46.
15. Helkala, E.-L., Koivisto, K., Hänninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., Mykkänen, L., Kesäniemi, Y. A., Laakso, M., & Riekkinen, P., Sr. (1995). The association of apolipoprotein E polymorphism with memory: A population based study. Neuroscience Letters, 191, 141-144.
16. Henderson, A. S., Easteal, S., Jorm, A. F., Mackinnon A. J., Korten, A. E., Christensen, H., Croft, L., & Jacomb, P. A. (1995). Apolipoprotein E allele ε4 dementia, and cognitive decline in a population sample. Lancet, 346, 1387-1390.
17. Howieson, D. B., Holm, L. A., Kaye, J. A., Oken, B. S., & Howieson, J. (1993). Neurologic function in the optimally healthy oldest old: Neuropsychological evaluation. Neurology, 43, 1882-1886.
18. Hui, S. L., Gao, S., Hall, K. S., Sahota, A., & Hendrie, H. C. (1996). Association of the ε4 allele of apolipoprotein E with poor performance on a dementia screen in African Americans. Ethnicity and Disease, 6, 266-271.
19. Hyman, B. T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., & Wallace, R. (1996). Apolipoprotein and cognitive change in an elderly population. Annals of Neurology, 40, 55-66.
20. Jack, C. R., Petersen, R. C., Xu, Y. C., O'Brien, P. C., Smith, G. E., Ivnik, R J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999). Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology, 52, 1397-1403.
21. Jonker, C., Schmand, B., Lindeboom, J., Havekes, L. M., & Launer, L. J. (1998). Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065-1069.
22. Kaplan, E. F., Goodglass, H., & Weintraub, S. (1978). The Boston Naming Test. Boston: Veterans Administration Medical Center.
23. Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A. D., Hyman, B. T., Crain, B., Tang, M-X., & Phelps, C. H. (1998). Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. New England Journal of Medicine, 338, 506-511.
24. Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tan, M.-X., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993). The apolipoprotein ε4 allele in patients with Alzheimer's disease. Annals of Neurology, 34, 752-754.
25. Meyer, M. R., Tschanz, J. T., & Norton, M. C. (1998). APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease. Nature Genetics, 19, 321-322.
26. Morris, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., Clark, C., & the CERAD investigators. (1989). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology, 39, 1159-1165.
27. Mortimer, J. A., & Graves, A. B. (1993). Education and other socioeconomic determinants of dementia and Alzheimer's disease. Neurology, 43, S39-S44.
28. Myers, R. H., Schaefer, E. J., Wilson, P. W. F., D'Agostino, R., Ordovas, J. M., Espino, A., Au, R., White, R. F., Knoefel, J. E., Cobb, J. L., McNulty, K. A., Beiser, A., & Wolf, P. A. (1996). Apolipoprotein E ε4 association with dementia in a population-based study: The Framingham Study. Neurology, 46, 673-677.
29. Payami, H., Grimslid, H., Oken, B., Camicioli, R., Sexton, G., Dame, A., Howieson, D., & Kaye, J. (1997). A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): Effects of family history and apolipoprotein E genotype. American Journal of Human Genetics, 60, 948-956.
30. Petersen, R. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., Thibodeau, S. N., Kokmen, E., Waring, S. C., & Kurland, L. T. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. Journal of the American Medical Association, 273, 1274-1278.
31. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Kokmen, E., & Tangelos, E. G. (1997). Aging, memory, and mild cognitive impairment. International Psychogeriatrics, 9(suppl. 1), 65-69.
32. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303-308.
33. Rebeck, G. W., Peris, T. T., West, H. L., Sodhi, P., Lipsitz, L. A., & Hyman, B. T. (1994). Reduced apolipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology, 44, 1513-1516.
34. Reed, T., Carmelli, D., Swan, G. E., Breitner, J. C. S., Welsh, K. A., Jarvik, G. P., Deeb, S., & Auwerx, J. (1994). Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Archives of Neurology, 51, 1189-1192.
35. Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. New England Journal of Medicine, 334, 752-758.
36. Rosen, W. G., Mohs, R. C, & Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356-1364.
37. Roses, A. D. (1995). Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Annals of Neurology, 38, 6-14.
38. Rowe, J. W., & Kahn, R. L. (1987). Human aging: Usual and successful. Science, 237, 143-149.
39. Rowe, J. W., & Kahn, R. L. (1997). Successful aging. The Gerontologist, 37, 433-440.
40. SAS Institute. (1985). SAS user's guide: Statistics (Version 5). Cary, NG: Author.
41. Saunders, A. M., Hulette, C., Welsh-Bohmer, K. A., Schmechel, D. E., Burke, J. R., Alberts, M. J., Strittmatter, W. J., Breitner, J. C. S., Rosenberg, C., Scott, S. V., Gaskell, P. C., Jr., Pericak-Vance, M. A., & Roses, A. D. (1996). Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet, 348, 90-93.
42. Schulz, R., & Heckhausen, J. (1996). A life span model of successful aging. American Psychologist, 51, 702-714.
43. Seeman, T. E., Rodin, J., & Albert, M. (1993). Self-efficacy and cognitive performance in high-functioning older individuals: MacArthur Studies of Successful Aging. Journal of Aging and Health, 5, 455-474.
44. Shimamura, A. P., Berry, J. M., Mangels, J. A., Rusting, C. L., & Jurica, P. J. (1995). Memory and cognitive abilities in university professors: Evidence for successful aging. Psychological Science, 6, 271-277.
45. Small, B. J., Basun, H., & Bäckman, L. (1998). Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia. Psychology and Aging, 13, 80-87.
46. Smith, G. E., Bohac, D. L., Waring, S. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J., & Petersen, R. C. (1998). Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology, 50, 355-362.
47. Smith, G. E., Thibodeau, S., Tsai, M. S., & Tangalos, E. G. (1994). Evidence for evolving dementia in apolipoprotein (Apo-E) E4 positive normal elderly? Neurology, 44, A207.
48. Snowdon, D. A. (1997). Aging and Alzheimer's disease: Lessons from the Nun Study. The Gerontologist, 37, 150-156.
49. Snowdon, D. A., Greiner, L. H., Mortimer, J. A., Riley, K. P., Greiner, P. A., & Markesbery, W. R. (1997). Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. Journal of the American Medical Association, 277, 813-817.
50. Snowdon, D. A., Kemper, S. J., Mortimer, J. A., Greiner, L. H., Wekstein, D. R., & Markesbery, W. R. (1996). Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: Findings from the Nun Study. Journal of the American Medical Association, 275, 528-532.
51. Snowdon, D. A., Ostwald, S. K., Kane, R. L., & Keenan, N. L. (1989). Years of life with good and poor mental and physical function in the elderly. Journal of Clinical Epidemiology, 42, 1055-1066.
52. van Duijn, C. M., de Knijff, P., Wehnert, A., De Voecht, J., Bronzova, J. B., Havekes, L. M., Hofman, A., & Van Boreckhoven, C. (1995). The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease. Annals of Neurology, 37, 605-610.
53. Welsh, K. A., Butters, N., Mohs, R. C, Beekly, D., Edland, S., Fillenbaum, G., & Heyman, A. (1994). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part V. A normative study of the neuropsychological battery. Neurology, 44, 609-614.
54. Yaffe, K., Cauley, J., Sands, L., & Browner, W. (1997). Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Archives of Neurology, 54, 1110-1114.